Pharmaceutical kit comprising midodrine as an active drug substance
CA 2403958 A1 · Owner: Nycomed Austria Gmbh · Inventors: Olsen, Peder Mohr; Bertelsen, Poul; Skinhoj, Annette
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel pharmaceutical kit comprising controlled release pharmaceutical compositions for oral use containing midodrine and/or its active metabolite desglymidodrine and a relatively fast onset composition. The controlled release compositions are designed to release midodrine and/or desglymidodrine after oral intake in a manner which enables absorption to take place in the gastrointestinal tract so that a relatively fast peak plasma concentration of the active metabolite desglymidodrine is obtained followed by a prolonged and relatively constant plasma concentration of desglymidodrine. Also disclosed is a method for treated orthostatic hypotention and/or urinary incontinence the , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.